Bank of New Hampshire’s GSK GSK Stock Holding History

Bank of New Hampshire’s Portfolio GSK Stock Details GSK Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2024 Q4	–	Sell	-46	Closed	-$1.88K	–	468
2024 Q3	$1.88K	Hold	46	–	–	﹤0.01%	442
2024 Q2	$1.77K	Hold	46	–	–	﹤0.01%	464
2024 Q1	$1.97K	Hold	46	–	–	﹤0.01%	461
2023 Q4	$1.71K	Sell	46 -58	-56%	-$2.08K	﹤0.01%	455
2023 Q3	$3.77K	Hold	104	–	–	﹤0.01%	451
2023 Q2	$3.71K	Hold	104	–	–	﹤0.01%	464
2023 Q1	$3.7K	Hold	104	–	–	﹤0.01%	463
2022 Q4	$4K	Hold	104	–	–	﹤0.01%	474
2022 Q3	$3K	Hold	104	–	–	﹤0.01%	489
2022 Q2	$6K	Hold	104	–	–	﹤0.01%	471
2022 Q1	$6K	Buy	+104	New	+$5.65K	﹤0.01%	482

Other funds holding GSK

Dodge & Cox San Francisco, California $182B AUM 14.68% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return

JEST

JTC Employer Solutions Trustee St Helier, Jersey $1.25B AUM 41.83% 1-Year Est. Return

Fisher Asset Management Camas, Washington $336B AUM 34.66% 1-Year Est. Return

Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

Royal Bank of Canada Toronto, Ontario, Canada $570B AUM 27.57% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return

Bank of New Hampshire's GSK Position: Q4 2024 in Review

Bank of New Hampshire sold out of GSK (GSK) in Q4 2024, closing a stake of 46 shares — an estimated $1.88K sold.

Bank of New Hampshire first reported a position in GSK in Q1 2022 and held it in 11 quarters. The position peaked at $6K in Q2 2022. 849 funds tracked by Wall St. Rank hold GSK as of Q4 2024.

Bank of New Hampshire reported no remaining GSK position as of Q4 2024 after selling out during the quarter.
Bank of New Hampshire sold 46 GSK shares in Q4 2024, an estimated $1.88K.
Bank of New Hampshire first reported a position in GSK in Q1 2022 and held it in 11 quarters.
Bank of New Hampshire's GSK position peaked at $6K in Q2 2022.
849 funds tracked by Wall St. Rank held GSK as of Q4 2024.

Based on Bank of New Hampshire's 13F filing for Q4 2024, filed 7 Jan 2025.